Illegal Imports Of Wegovy, Mounjaro Triple In South Korea
The number of attempts to illegally import weight-loss medications, such as Wegovy and Mounjaro, from abroad in the…
Firms face pressure from shifting demand after weight-loss pills approved
Firms are to come under pressure to adapt to rapidly changing consumer demand as more than a third…
From GLP-1 hormone to weight-loss drug: How semaglutide is made and why quality matters
What does it really take to recreate one of today’s most talked-about medicines? As semaglutide gains traction worldwide,…
‘Super weight loss’ drug retatrutide could be available soon
KENT COUNTY, Mich — A new weight loss drug could soon be joining the growing list of medications…
Weight loss pill to reshape spending habits of millions of people, study finds
Weight loss medication entering into the mainstream could fundamentally reshape how millions of people shop and what retailers…
India embraces cheaper weight loss drugs but doctors are worried
Pankhuri Pareek wanted to return to a fit and healthy lifestyle after having her baby daughter but struggled…
‘The View’ Host Shares Bizarre Ozempic Side Effect
The View host Joy Behar suffered a weird side effect from her weight loss medication. “Ever since I…
Coming soon: Affordable weight-loss medication to Canada – Winnipeg Sun
Coming soon: Affordable weight-loss medication to Canada Winnipeg SunRegulator steps up oversight of GLP-1 drug distribution chain ET Pharma‘GLP-1 made…
What happens if I stop taking GLP-1 s for weight loss?
This article was reviewed by Mike Bohl, MD. If you’ve been using a GLP-1 such as semaglutide, then…
Ozempic and friends show surprising link to lower addiction risks, but experts urge caution
PARIS, March 6 — Taking a new generation of weight-loss medication is linked to a significantly lower risk…
Some GLP-1 Users Are Getting Scurvy
Some patients taking popular weight-loss drugs are ending up with a condition associated with 18th-century sea voyages:…
Does Medicare Cover Ozempic and Other Weight Loss Drugs?
About 9 percent of adults 65 and older are now using GLP-1s, a lower rate than the 22…